EPISODE · May 8, 2023 · 1H 3M
Ep135: John Maraganore on Developing a New Class of Medicines
from The Long Run with Luke Timmerman · host Timmerman Report
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
What this episode covers
John Maraganore, former founding CEO of Alnylam Pharmaceuticals, on his life in biotech and developing RNA interference as a new class of medicine.
NOW PLAYING
Ep135: John Maraganore on Developing a New Class of Medicines
No transcript for this episode yet
Similar Episodes
Mar 26, 2026 ·1m
Mar 19, 2026 ·34m
Feb 18, 2026 ·11m
Feb 11, 2026 ·45m